Source: https://www.lawlio.com/regulations/21/cfr
Timestamp: 2019-04-24 20:10:24+00:00

Document:
§ 1.20 Presence of mandatory label information.
§ 1.21 Failure to reveal material facts.
§ 1.23 Procedures for requesting variations and exemptions from required label statements.
§ 1.24 Exemptions from required label statements.
§ 1.72 Data elements that must be submitted in ACE for articles regulated by FDA.
§ 1.77 Radiation-emitting electronic products.
§ 1.78 Biological products, HCT/Ps, and related drugs and medical devices.
§ 1.81 Rejection of entry filing.
§ 1.90 Notice of sampling.
§ 1.91 Payment for samples.
§ 1.94 Hearing on refusal of admission or destruction.
§ 1.95 Application for authorization to relabel and recondition.
§ 1.96 Granting of authorization to relabel and recondition.
§ 1.99 Costs chargeable in connection with relabeling and reconditioning inadmissible imports.
§ 1.101 Notification and recordkeeping.
§ 1.500 What definitions apply to this subpart?
§ 1.501 To what foods do the requirements in this subpart apply?
§ 1.502 What foreign supplier verification program (FSVP) must I have?
§ 1.503 Who must develop my FSVP and perform FSVP activities?
§ 1.504 What hazard analysis must I conduct?
§ 1.505 What evaluation for foreign supplier approval and verification must I conduct?
§ 1.506 What foreign supplier verification and related activities must I conduct?
§ 1.507 What requirements apply when I import a food that cannot be consumed without the hazards being controlled or for which the hazards are controlled after importation?
§ 1.508 What corrective actions must I take under my FSVP?
§ 1.509 How must the importer be identified at entry?
§ 1.510 How must I maintain records of my FSVP?
§ 1.511 What FSVP must I have if I am importing a food subject to certain requirements in the dietary supplement current good manufacturing practice regulation?
§ 1.512 What FSVP may I have if I am a very small importer or I am importing certain food from certain small foreign suppliers?
§ 1.513 What FSVP may I have if I am importing certain food from a country with an officially recognized or equivalent food safety system?
§ 1.514 What are some consequences of failing to comply with the requirements of this subpart?
§ 1.600 What definitions apply to this subpart?
§ 1.601 Who is subject to this subpart?
§ 1.980 Administrative detention of drugs.
§ 2.5 Imminent hazard to the public health.
§ 2.10 Examination and investigation samples.
§ 2.19 Methods of analysis.
§ 2.25 Grain seed treated with poisonous substances; color identification to prevent adulteration of human and animal food.
§ 2.35 Use of secondhand containers for the shipment or storage of food and animal feed.
§ 2.110 Definition of ammonia under Federal Caustic Poison Act.
§ 2.125 Use of ozone-depleting substances in foods, drugs, devices, or cosmetics.
§ 3.4 Designated agency component.
§ 3.5 Procedures for identifying the designated agency component.
§ 3.6 Product jurisdiction officer.
§ 3.7 Request for designation.
§ 3.8 Letter of designation.
§ 3.9 Effect of letter of designation.
§ 3.10 Stay of review time.
§ 5.1105 Chief Counsel, Food and Drug Administration.
§ 5.1110 FDA public information offices.
§ 7.13 Suggested forms of guaranty.
§ 7.41 Health hazard evaluation and recall classification.
§ 7.45 Food and Drug Administration-requested recall.
§ 7.50 Public notification of recall.
§ 7.53 Recall status reports.
§ 7.55 Termination of a recall.
§ 7.59 General industry guidance.
§ 7.84 Opportunity for presentation of views before report of criminal violation.
§ 7.85 Conduct of a presentation of views before report of criminal violation.
§ 7.87 Records related to opportunities for presentation of views conducted before report of criminal violation.
§ 10.10 Summaries of administrative practices and procedures.
§ 10.19 Waiver, suspension, or modification of procedural requirements.
§ 10.20 Submission of documents to Division of Dockets Management; computation of time; availability for public disclosure.
§ 10.25 Initiation of administrative proceedings.
§ 10.31 Citizen petitions and petitions for stay of action related to abbreviated new drug applications, certain new drug applications, or certain biologics license applications.
§ 10.33 Administrative reconsideration of action.
§ 10.35 Administrative stay of action.
§ 10.40 Promulgation of regulations for the efficient enforcement of the law.
§ 10.45 Court review of final administrative action; exhaustion of administrative remedies.
§ 10.50 Promulgation of regulations and orders after an opportunity for a formal evidentiary public hearing.
§ 10.55 Separation of functions; ex parte communications.
§ 10.60 Referral by court.
§ 10.65 Meetings and correspondence.
§ 10.70 Documentation of significant decisions in administrative file.
§ 10.75 Internal agency review of decisions.
§ 10.80 Dissemination of draft Federal Register notices and regulations.
§ 10.90 Food and Drug Administration regulations, recommendations, and agreements.
§ 10.95 Participation in outside standard-setting activities.
§ 10.105 Representation by an organization.
§ 10.115 Good guidance practices.
§ 10.205 Electronic media coverage of public administrative proceedings.
§ 10.206 Procedures for electronic media coverage of agency public administrative proceedings.
§ 11.10 Controls for closed systems.
§ 11.30 Controls for open systems.
§ 11.200 Electronic signature components and controls.
§ 11.300 Controls for identification codes/passwords.
§ 12.20 Initiation of a hearing involving the issuance, amendment, or revocation of a regulation.
§ 12.21 Initiation of a hearing involving the issuance, amendment, or revocation of an order.
§ 12.22 Filing objections and requests for a hearing on a regulation or order.
§ 12.23 Notice of filing of objections.
§ 12.24 Ruling on objections and requests for hearing.
§ 12.26 Modification or revocation of regulation or order.
§ 12.28 Denial of hearing in whole or in part.
§ 12.30 Judicial review after waiver of hearing on a regulation.
§ 12.32 Request for alternative form of hearing.
§ 12.35 Notice of hearing; stay of action.
§ 12.37 Effective date of a regulation.
§ 12.38 Effective date of an order.
§ 12.45 Notice of participation.
§ 12.50 Advice on public participation in hearings.
§ 12.62 Commencement of functions.
§ 12.70 Authority of presiding officer.
§ 12.75 Disqualification of presiding officer.
§ 12.78 Unavailability of presiding officer.
§ 12.80 Filing and service of submissions.
§ 12.82 Petition to participate in forma pauperis.
§ 12.85 Disclosure of data and information by the participants.
§ 12.87 Purpose; oral and written testimony; burden of proof.
§ 12.89 Participation of nonparties.
§ 12.90 Conduct at oral hearings or conferences.
§ 12.91 Time and place of prehearing conference.
§ 12.92 Prehearing conference procedure.
§ 12.94 Receipt of evidence.
§ 12.96 Briefs and arguments.
§ 12.97 Interlocutory appeal from ruling of presiding officer.
§ 12.100 Administrative record of a hearing.
§ 12.105 Examination of record.
§ 12.125 Appeal from or review of initial decision.
§ 12.130 Decision by Commissioner on appeal or review of initial decision.
§ 12.139 Reconsideration and stay of action.
§ 12.140 Review by the courts.
§ 12.159 Copies of petitions for judicial review.
§ 13.5 Notice of a hearing before a Board.
§ 13.10 Members of a Board.
§ 13.15 Separation of functions; ex parte communications; administrative support.
§ 13.20 Submissions to a Board.
§ 13.25 Disclosure of data and information by the participants.
§ 13.30 Proceedings of a Board.
§ 13.40 Administrative record of a Board.
§ 13.45 Examination of administrative record.
§ 13.50 Record for administrative decision.
§ 14.5 Purpose of proceedings before an advisory committee.
§ 14.10 Applicability to Congress.
§ 14.15 Committees working under a contract with FDA.
§ 14.20 Notice of hearing before an advisory committee.
§ 14.22 Meetings of an advisory committee.
§ 14.25 Portions of advisory committee meetings.
§ 14.27 Determination to close portions of advisory committee meetings.
§ 14.29 Conduct of a hearing before an advisory committee.
§ 14.30 Chairperson of an advisory committee.
§ 14.31 Consultation by an advisory committee with other persons.
§ 14.33 Compilation of materials for members of an advisory committee.
§ 14.35 Written submissions to an advisory committee.
§ 14.39 Additional rules for a particular advisory committee.
§ 14.40 Establishment and renewal of advisory committees.
§ 14.55 Termination of advisory committees.
§ 14.60 Minutes and reports of advisory committee meetings.
§ 14.61 Transcripts of advisory committee meetings.
§ 14.65 Public inquiries and requests for advisory committee records.
§ 14.70 Administrative record of a public hearing before an advisory committee.
§ 14.75 Examination of administrative record and other advisory committee records.
§ 14.80 Qualifications for members of standing policy and technical advisory committees.
§ 14.82 Nominations of voting members of standing advisory committees.
§ 14.84 Nominations and selection of nonvoting members of standing technical advisory committees.
§ 14.86 Rights and responsibilities of nonvoting members of advisory committees.
§ 14.90 Ad hoc advisory committee members.
§ 14.95 Compensation of advisory committee members.
§ 14.100 List of standing advisory committees.
§ 14.120 Establishment of the Technical Electronic Product Radiation Safety Standards Committee (TEPRSSC).
§ 14.122 Functions of TEPRSSC.
§ 14.125 Procedures of TEPRSSC.
§ 14.127 Membership of TEPRSSC.
§ 14.130 Conduct of TEPRSSC meeting; availability of TEPRSSC records.
§ 14.140 Establishment of a color additive advisory committee.
§ 14.142 Functions of a color additive advisory committee.
§ 14.145 Procedures of a color additive advisory committee.
§ 14.147 Membership of a color additive advisory committee.
§ 14.155 Fees and compensation pertaining to a color additive advisory committee.
§ 14.160 Establishment of standing technical advisory committees for human prescription drugs.
§ 14.171 Utilization of an advisory committee on the initiative of FDA.
§ 14.172 Utilization of an advisory committee at the request of an interested person.
§ 14.174 Advice and recommendations in writing.
§ 15.20 Notice of a public hearing before the Commissioner.
§ 15.21 Notice of participation; schedule for hearing.
§ 15.30 Conduct of a public hearing before the Commissioner.
§ 15.45 Examination of administrative record.
§ 16.22 Initiation of regulatory hearing.
§ 16.24 Regulatory hearing required by the act or a regulation.
§ 16.26 Denial of hearing and summary decision.
§ 17.2 Maximum penalty amounts.
§ 17.7 Service of complaint.
§ 17.11 Default upon failure to file an answer.
§ 17.13 Notice of hearing.
§ 17.15 Parties to the hearing.
§ 17.18 Interlocutory appeal from ruling of presiding officer.
§ 17.19 Authority of the presiding officer.
§ 17.20 Ex parte contacts.
§ 17.25 Exchange of witness lists, witness statements, and exhibits.
§ 17.30 Computation of time.
§ 17.31 Form, filing, and service of papers.
§ 17.33 The hearing and burden of proof.
§ 17.34 Determining the amount of penalties and assessments.
§ 17.41 The administrative record.
§ 17.54 Deposit in the Treasury of the United States.
§ 19.5 Reference to Department regulations.
§ 19.6 Code of ethics for government service.
§ 19.10 Food and Drug Administration Conflict of Interest Review Board.
§ 19.21 Duty to report violations.
§ 19.45 Temporary disqualification of former employees.
§ 19.55 Permanent disqualification of former employees.
§ 20.1 Testimony by Food and Drug Administration employees.
§ 20.2 Production of records by Food and Drug Administration employees.
§ 20.3 Certification and authentication of Food and Drug Administration records.
§ 20.20 Policy on disclosure of Food and Drug Administration records.
§ 20.21 Uniform access to records.
§ 20.22 Partial disclosure of records.
§ 20.23 Request for existing records.
§ 20.24 Preparation of new records.
§ 20.25 Retroactive application of regulations.
§ 20.26 Indexes of certain records.
§ 20.27 Submission of records marked as confidential.
§ 20.28 Food and Drug Administration determinations of confidentiality.
§ 20.29 Prohibition on withdrawal of records from Food and Drug Administration files.
§ 20.30 Food and Drug Administration Division of Freedom of Information.
§ 20.31 Retention schedule of requests for Food and Drug Administration records.
§ 20.32 Disclosure of Food and Drug Administration employee names.
§ 20.33 Form or format of response.
§ 20.34 Search for records.
§ 20.40 Filing a request for records.
§ 20.42 Aggregation of certain requests.
§ 20.45 Fees to be charged.
§ 20.46 Waiver or reduction of fees.
§ 20.47 Situations in which confidentiality is uncertain.
§ 20.48 Judicial review of proposed disclosure.
§ 20.49 Denial of a request for records.
§ 20.50 Nonspecific and overly burdensome requests.
§ 20.51 Referral to primary source of records.
§ 20.52 Availability of records at National Technical Information Service.
§ 20.53 Use of private contractor for copying.
§ 20.54 Request for review without copying.
§ 20.55 Indexing trade secrets and confidential commercial or financial information.
§ 20.60 Applicability of exemptions.
§ 20.61 Trade secrets and commercial or financial information which is privileged or confidential.
§ 20.62 Inter- or intra-agency memoranda or letters.
§ 20.63 Personnel, medical, and similar files, disclosure of which constitutes a clearly unwarranted invasion of personal privacy.
§ 20.64 Records or information compiled for law enforcement purposes.
§ 20.65 National defense and foreign policy.
§ 20.66 Internal personnel rules and practices.
§ 20.67 Records exempted by other statutes.
§ 20.80 Applicability of limitations on exemptions.
§ 20.81 Data and information previously disclosed to the public.
§ 20.82 Discretionary disclosure by the Commissioner.
§ 20.83 Disclosure required by court order.
§ 20.84 Disclosure to consultants, advisory committees, State and local government officials commissioned pursuant to 21 U.S.C. 372(a), and other special government employees.
§ 20.85 Disclosure to other Federal government departments and agencies.
§ 20.86 Disclosure in administrative or court proceedings.
§ 20.87 Disclosure to Congress.
§ 20.88 Communications with State and local government officials.
§ 20.89 Communications with foreign government officials.
§ 20.90 Disclosure to contractors.
§ 20.91 Use of data or information for administrative or court enforcement action.
§ 20.100 Applicability; cross-reference to other regulations.
§ 20.101 Administrative enforcement records.
§ 20.102 Court enforcement records.
§ 20.104 Summaries of oral discussions.
§ 20.105 Testing and research conducted by or with funds provided by the Food and Drug Administration.
§ 20.106 Studies and reports prepared by or with funds provided by the Food and Drug Administration.
§ 20.107 Food and Drug Administration manuals.
§ 20.108 Agreements between the Food and Drug Administration and other departments, agencies, and organizations.
§ 20.109 Data and information obtained by contract.
§ 20.110 Data and information about Food and Drug Administration employees.
§ 20.111 Data and information submitted voluntarily to the Food and Drug Administration.
§ 20.112 Voluntary drug experience reports submitted by physicians and hospitals.
§ 20.113 Voluntary product defect reports.
§ 20.114 Data and information submitted pursuant to cooperative quality assurance agreements.
§ 20.115 Product codes for manufacturing or sales dates.
§ 20.116 Drug and device registration and listing information.
§ 20.117 New drug information.
§ 20.118 Advisory committee records.
§ 20.119 Lists of names and addresses.
§ 20.120 Records available in Food and Drug Administration Public Reading Rooms.
§ 21.10 Policy concerning records about individuals.
§ 21.20 Procedures for notice of Food and Drug Administration Privacy Act Record Systems.
§ 21.21 Changes in systems and new systems.
§ 21.30 Records of contractors.
§ 21.31 Records stored by the National Archives and Records Administration.
§ 21.40 Procedures for submitting requests for notification and access.
§ 21.41 Processing of requests.
§ 21.42 Responses to requests.
§ 21.43 Access to requested records.
§ 21.44 Verification of identity.
§ 21.50 Procedures for submitting requests for amendment of records.
§ 21.51 Responses to requests for amendment of records.
§ 21.52 Administrative appeals of refusals to amend records.
§ 21.53 Notation and disclosure of disputed records.
§ 21.54 Amended or disputed records received from other agencies.
§ 21.65 Access to records in exempt systems.
§ 21.70 Disclosure and intra-agency use of records in Privacy Act Record Systems; no accounting required.
§ 21.71 Disclosure of records in Privacy Act Record Systems; accounting required.
§ 21.72 Individual consent to disclosure of records to other persons.
§ 21.73 Accuracy, completeness, timeliness, and relevance of records disclosed from Privacy Act Record Systems.
§ 21.74 Providing notice that a record is disputed.
§ 21.75 Rights of legal guardians.
§ 25.10 Policies and NEPA planning.
§ 25.16 Public health and safety emergencies.
§ 25.20 Actions requiring preparation of an environmental assessment.
§ 25.22 Actions requiring the preparation of an environmental impact statement.
§ 25.31 Human drugs and biologics.
§ 25.32 Foods, food additives, and color additives.
§ 25.34 Devices and electronic products.
§ 25.35 Tobacco product applications.
§ 25.41 Findings of no significant impact.
§ 25.42 Environmental impact statements.
§ 25.43 Records of decision.
§ 25.44 Lead and cooperating agencies.
§ 25.45 Responsible agency official.
§ 25.51 Environmental assessments and findings of no significant impact.
§ 25.52 Environmental impact statements.
§ 25.60 Environmental effects abroad of major agency actions.
§ 26.5 Length of transition period.
§ 26.7 Participation in the equivalence assessment and determination.
§ 26.8 Other transition activities.
§ 26.10 Regulatory authorities not listed as currently equivalent.
§ 26.11 Start of operational period.
§ 26.12 Nature of recognition of inspection reports.
§ 26.13 Transmission of postapproval inspection reports.
§ 26.14 Transmission of preapproval inspection reports.
§ 26.15 Monitoring continued equivalence.
§ 26.17 Role and composition of the Joint Sectoral Committee.
§ 26.19 Information relating to quality aspects.
§ 26.35 Length and purpose of transition period.
§ 26.36 Listing of CAB's.
§ 26.37 Confidence building activities.
§ 26.38 Other transition period activities.
§ 26.40 Start of the operational period.
§ 26.41 Exchange and endorsement of quality system evaluation reports.
§ 26.42 Exchange and endorsement of product evaluation reports.
§ 26.43 Transmission of quality system evaluation reports.
§ 26.44 Transmission of product evaluation reports.
§ 26.45 Monitoring continued equivalence.
§ 26.46 Listing of additional CAB's.
§ 26.47 Role and composition of the Joint Sectoral Committee.
§ 26.50 Alert system and exchange of postmarket vigilance reports.
§ 26.61 Purpose of this part.
§ 26.63 General coverage of this part.
§ 26.66 Designation and listing procedures.
§ 26.67 Suspension of listed conformity assessment bodies.
§ 26.68 Withdrawal of listed conformity assessment bodies.
§ 26.69 Monitoring of conformity assessment bodies.
§ 26.70 Conformity assessment bodies.
§ 26.71 Exchange of information.
§ 26.72 Sectoral contact points.
§ 26.74 Preservation of regulatory authority.
§ 26.75 Suspension of recognition obligations.
§ 26.78 Agreements with other countries.
§ 26.80 Entry into force, amendment, and termination.
§ 50.20 General requirements for informed consent.
§ 50.23 Exception from general requirements.
§ 50.24 Exception from informed consent requirements for emergency research.
§ 50.25 Elements of informed consent.
§ 50.27 Documentation of informed consent.
§ 50.51 Clinical investigations not involving greater than minimal risk.
§ 50.52 Clinical investigations involving greater than minimal risk but presenting the prospect of direct benefit to individual subjects.
§ 50.55 Requirements for permission by parents or guardians and for assent by children.
§ 54.4 Certification and disclosure requirements.
§ 54.5 Agency evaluation of financial interests.
§ 54.6 Recordkeeping and record retention.
§ 56.103 Circumstances in which IRB review is required.
§ 56.105 Waiver of IRB requirement.
§ 56.109 IRB review of research.
§ 56.112 Review by institution.
§ 56.113 Suspension or termination of IRB approval of research.
§ 56.120 Lesser administrative actions.
§ 56.121 Disqualification of an IRB or an institution.
§ 56.122 Public disclosure of information regarding revocation.
§ 56.123 Reinstatement of an IRB or an institution.
§ 56.124 Actions alternative or additional to disqualification.
§ 58.43 Animal care facilities.
§ 58.45 Animal supply facilities.
§ 58.47 Facilities for handling test and control articles.
§ 58.49 Laboratory operation areas.
§ 58.51 Specimen and data storage facilities.
§ 58.130 Conduct of a nonclinical laboratory study.
§ 58.185 Reporting of nonclinical laboratory study results.
§ 58.190 Storage and retrieval of records and data.
§ 58.195 Retention of records.
§ 60.10 FDA assistance on eligibility.
§ 60.20 FDA action on regulatory review period determinations.
§ 60.22 Regulatory review period determinations.
§ 60.24 Revision of regulatory review period determinations.
§ 60.26 Final action on regulatory review period determinations.
§ 60.28 Time frame for determining regulatory review periods.
§ 60.30 Filing, format, and content of petitions.
§ 60.32 Applicant response to petition.
§ 60.34 FDA action on petitions.
§ 60.36 Standard of due diligence.
§ 60.40 Request for hearing.
§ 60.42 Notice of hearing.
§ 70.5 General restrictions on use of color additives.
§ 70.10 Color additives in standardized foods and new drugs.
§ 70.19 Fees for listing.
§ 70.20 Packaging requirements for straight colors (other than hair dyes).
§ 70.25 Labeling requirements for color additives (other than hair dyes).
§ 70.40 Safety factors to be considered.
§ 70.42 Criteria for evaluating the safety of color additives.
§ 70.45 Allocation of color additives.
§ 70.50 Application of the cancer clause of section 721 of the act.
§ 70.51 Advisory committee on the applicability of the anticancer clause.
§ 70.55 Request for scientific studies.
§ 71.2 Notice of filing of petition.
§ 71.4 Samples; additional information.
§ 71.15 Confidentiality of data and information in color additive petitions.
§ 71.18 Petition for exemption from certification.
§ 73.1 Diluents in color additive mixtures for food use exempt from certification.
§ 73.40 Dehydrated beets (beet powder).
§ 73.100 Cochineal extract; carmine.
§ 73.125 Sodium copper chlorophyllin.
§ 73.140 Toasted partially defatted cooked cottonseed flour.
§ 73.169 Grape color extract.
§ 73.170 Grape skin extract (enocianina).
§ 73.185 Haematococcus algae meal.
§ 73.200 Synthetic iron oxide.
§ 73.275 Dried algae meal.
§ 73.295 Tagetes (Aztec marigold) meal and extract.
§ 73.315 Corn endosperm oil.
§ 73.350 Mica-based pearlescent pigments.
§ 73.585 Tomato lycopene extract; tomato lycopene concentrate.
§ 73.1001 Diluents in color additive mixtures for drug use exempt from certification.
§ 73.1010 Alumina (dried aluminum hydroxide).
§ 73.1025 Ferric ammonium citrate.
§ 73.1100 Cochineal extract; carmine.
§ 73.1125 Potassium sodium copper chloropyhllin (chlorophyllin-copper complex).
§ 73.1200 Synthetic iron oxide.
§ 73.1298 Ferric ammonium ferrocyanide.
§ 73.1326 Chromium hydroxide green.
§ 73.1327 Chromium oxide greens.
§ 73.1350 Mica-based pearlescent pigments.
§ 73.2125 Potassium sodium copper chlorophyllin (chlorophyllin-copper complex).
§ 73.2298 Ferric ammonium ferrocyanide.
§ 73.2326 Chromium hydroxide green.
§ 73.2327 Chromium oxide greens.
§ 73.2995 Luminescent zinc sulfide.
§ 73.3100 1,4-Bis[(2-hydroxyethyl)amino]-9,10-anthracenedione bis(2-methyl-2-propenoic)ester copolymers.
§ 73.3106 1,4-Bis[4-(2-methacryloxyethyl) phenylamino]anthraquinone copolymers.
§ 73.3110 Chlorophyllin-copper complex, oil soluble.
§ 73.3111 Chromium oxide greens.
§ 73.3112 C.I. Vat Orange 1.
§ 73.3117 16,23-Dihydrodinaphtho[2,3-a:2′,3′-i] naphth [2′,3′:6,7] indolo [2,3-c] carbazole-5,10,15,17,22,24-hexone.
§ 73.3120 16,17-Dimethoxydinaphtho [1,2,3-cd:3′,2′,1′-lm] perylene-5,10-dione.
§ 73.3121 Poly(hydroxyethyl methacrylate)-dye copolymers.
§ 73.3123 6-Ethoxy-2-(6-ethoxy-3-oxobenzo[b]thien-2(3H)-ylidene) benzo[b]thiophen-3 (2H)-one.
§ 73.3127 Vinyl alcohol/methyl methacrylate-dye reaction products.
§ 73.3128 Mica-based pearlescent pigments.
§ 74.101 FD&C Blue No. 1.
§ 74.203 FD&C Green No. 3.
§ 74.302 Citrus Red No. 2.
§ 74.303 FD&C Red No. 3.
§ 74.340 FD&C Red No. 40.
§ 74.705 FD&C Yellow No. 5.
§ 74.706 FD&C Yellow No. 6.
§ 74.1102 FD&C Blue No. 2.
§ 74.1104 D&C Blue No. 4.
§ 74.1109 D&C Blue No. 9.
§ 74.1203 FD&C Green No. 3.
§ 74.1205 D&C Green No. 5.
§ 74.1206 D&C Green No. 6.
§ 74.1208 D&C Green No. 8.
§ 74.1254 D&C Orange No. 4.
§ 74.1255 D&C Orange No. 5.
§ 74.1260 D&C Orange No. 10.
§ 74.1261 D&C Orange No. 11.
§ 74.1303 FD&C Red No. 3.
§ 74.1304 FD&C Red No. 4.
§ 74.1306 D&C Red No. 6.
§ 74.1307 D&C Red No. 7.
§ 74.1317 D&C Red No. 17.
§ 74.1321 D&C Red No. 21.
§ 74.1322 D&C Red No. 22.
§ 74.1327 D&C Red No. 27.
§ 74.1328 D&C Red No. 28.
§ 74.1330 D&C Red No. 30.
§ 74.1331 D&C Red No. 31.
§ 74.1333 D&C Red No. 33.
§ 74.1334 D&C Red No. 34.
§ 74.1336 D&C Red No. 36.
§ 74.1339 D&C Red No. 39.
§ 74.1340 FD&C Red No. 40.
§ 74.1602 D&C Violet No. 2.
§ 74.1705 FD&C Yellow No. 5.
§ 74.1706 FD&C Yellow No. 6.
§ 74.1707 D&C Yellow No. 7.
§ 74.1707a Ext. D&C Yellow No. 7.
§ 74.1708 D&C Yellow No. 8.
§ 74.1710 D&C Yellow No. 10.
§ 74.1711 D&C Yellow No. 11.
§ 74.2052 D&C Black No. 2.
§ 74.2053 D&C Black No. 3.
§ 74.2101 FD&C Blue No. 1.
§ 74.2104 D&C Blue No. 4.
§ 74.2151 D&C Brown No. 1.
§ 74.2203 FD&C Green No. 3.
§ 74.2205 D&C Green No. 5.
§ 74.2206 D&C Green No. 6.
§ 74.2208 D&C Green No. 8.
§ 74.2254 D&C Orange No. 4.
§ 74.2255 D&C Orange No. 5.
§ 74.2260 D&C Orange No. 10.
§ 74.2261 D&C Orange No. 11.
§ 74.2304 FD&C Red No. 4.
§ 74.2306 D&C Red No. 6.
§ 74.2317 D&C Red No. 17.
§ 74.2321 D&C Red No. 21.
§ 74.2322 D&C Red No. 22.
§ 74.2327 D&C Red No. 27.
§ 74.2328 D&C Red No. 28.
§ 74.2330 D&C Red No. 30.
§ 74.2331 D&C Red No. 31.
§ 74.2333 D&C Red No. 33.
§ 74.2334 D&C Red No. 34.
§ 74.2336 D&C Red No. 36.
§ 74.2340 FD&C Red No. 40.
§ 74.2602 D&C Violet No. 2.
§ 74.2602a Ext. D&C Violet No. 2.
§ 74.2705 FD&C Yellow No. 5.
§ 74.2706 FD&C Yellow No. 6.
§ 74.2707 D&C Yellow No. 7.
§ 74.2707a Ext. D&C Yellow No. 7.
§ 74.2708 D&C Yellow No. 8.
§ 74.2710 D&C Yellow No. 10.
§ 74.2711 D&C Yellow No. 11.
§ 74.3102 FD&C Blue No. 2.
§ 74.3106 D&C Blue No. 6.
§ 74.3206 D&C Green No. 6.
§ 74.3230 D&C Red No. 17.
§ 74.3602 D&C Violet No. 2.
§ 74.3710 D&C Yellow No. 10.
§ 80.10 Fees for certification services.
§ 80.21 Request for certification.
§ 80.22 Samples to accompany requests for certification.
§ 80.32 Limitations of certificates.
§ 80.34 Authority to refuse certification service.
§ 80.35 Color additive mixtures; certification and exemption from certification.
§ 80.37 Treatment of batch pending certification.
§ 80.38 Treatment of batch after certification.
§ 80.39 Records of distribution.
§ 82.5 General specifications for straight colors.
§ 82.101 FD&C Blue No. 1.
§ 82.102 FD&C Blue No. 2.
§ 82.203 FD&C Green No. 3.
§ 82.304 FD&C Red No. 4.
§ 82.705 FD&C Yellow No. 5.
§ 82.706 FD&C Yellow No. 6.
§ 82.1104 D&C Blue No. 4.
§ 82.1205 D&C Green No. 5.
§ 82.1206 D&C Green No. 6.
§ 82.1254 D&C Orange No. 4.
§ 82.1255 D&C Orange No. 5.
§ 82.1260 D&C Orange No. 10.
§ 82.1261 D&C Orange No. 11.
§ 82.1306 D&C Red No. 6.
§ 82.1307 D&C Red No. 7.
§ 82.1317 D&C Red No. 17.
§ 82.1321 D&C Red No. 21.
§ 82.1322 D&C Red No. 22.
§ 82.1327 D&C Red No. 27.
§ 82.1328 D&C Red No. 28.
§ 82.1330 D&C Red No. 30.
§ 82.1331 D&C Red No. 31.
§ 82.1333 D&C Red No. 33.
§ 82.1334 D&C Red No. 34.
§ 82.1336 D&C Red No. 36.
§ 82.1602 D&C Violet No. 2.
§ 82.1707 D&C Yellow No. 7.
§ 82.1708 D&C Yellow No. 8.
§ 82.1710 D&C Yellow No. 10.
§ 82.2051 Lakes (Ext. D&C).
§ 82.2707a Ext. D&C Yellow No. 7.
§ 99.101 Information that may be disseminated.
§ 99.103 Mandatory statements and information.
§ 99.105 Recipients of information.
§ 99.201 Manufacturer's submission to the agency.
§ 99.203 Request to extend the time for completing planned studies.
§ 99.205 Application for exemption from the requirement to file a supplemental application.
§ 99.301 Agency action on a submission.
§ 99.303 Extension of time for completing planned studies.
§ 99.305 Exemption from the requirement to file a supplemental application.
§ 99.401 Corrective actions and cessation of dissemination of information.
§ 99.403 Termination of approvals of applications for exemption.
§ 99.405 Applicability of labeling, adulteration, and misbranding authority.
§ 99.501 Recordkeeping and reports.

References: § 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 1

§ 2

§ 2

§ 2

§ 2

§ 2

§ 2

§ 2

§ 3

§ 3

§ 3

§ 3

§ 3

§ 3

§ 3

§ 5

§ 5

§ 7

§ 7

§ 7

§ 7

§ 7

§ 7

§ 7

§ 7

§ 7

§ 7

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 10

§ 11

§ 11

§ 11

§ 11

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 12

§ 13

§ 13

§ 13

§ 13

§ 13

§ 13

§ 13

§ 13

§ 13

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 14

§ 15

§ 15

§ 15

§ 15

§ 16

§ 16

§ 16

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 17

§ 19

§ 19

§ 19

§ 19

§ 19

§ 19

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 20

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 21

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 25

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 26

§ 50

§ 50

§ 50

§ 50

§ 50

§ 50

§ 50

§ 50

§ 54

§ 54

§ 54

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 58

§ 58

§ 58

§ 58

§ 58

§ 58

§ 58

§ 58

§ 58

§ 60

§ 60

§ 60

§ 60

§ 60

§ 60

§ 60

§ 60

§ 60

§ 60

§ 60

§ 60

§ 70

§ 70

§ 70

§ 70

§ 70

§ 70

§ 70

§ 70

§ 70

§ 70

§ 70

§ 71

§ 71

§ 71

§ 71

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 73

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 74

§ 80

§ 80

§ 80

§ 80

§ 80

§ 80

§ 80

§ 80

§ 80

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 82

§ 99

§ 99

§ 99

§ 99

§ 99

§ 99

§ 99

§ 99

§ 99

§ 99

§ 99

§ 99

§ 99